Merrick I. Ross

805 total citations
15 papers, 609 citations indexed

About

Merrick I. Ross is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Merrick I. Ross has authored 15 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 3 papers in Surgery and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Merrick I. Ross's work include Vascular Tumors and Angiosarcomas (3 papers), CAR-T cell therapy research (3 papers) and Immunotherapy and Immune Responses (3 papers). Merrick I. Ross is often cited by papers focused on Vascular Tumors and Angiosarcomas (3 papers), CAR-T cell therapy research (3 papers) and Immunotherapy and Immune Responses (3 papers). Merrick I. Ross collaborates with scholars based in United States, Netherlands and Switzerland. Merrick I. Ross's co-authors include Raphael E. Pollock, Nora A. Janjan, Marvin M. Romsdahl, Robert S. Benjamin, Haim Gutman, Frederick C. Ames, Charles M. Balch, S. Eva Singletary, Gregory P. Reece and Stephen S. Kroll and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

Merrick I. Ross

15 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Merrick I. Ross United States	11	322	217	155	153	150	15	609
Rouzan G. Karabakhtsian United States	13	180 0.6×	115 0.5×	181 1.2×	221 1.4×	117 0.8×	34	599
Charles D. Callery United States	8	266 0.8×	106 0.5×	48 0.3×	82 0.5×	148 1.0×	14	457
Tanuja Shet India	12	279 0.9×	93 0.4×	98 0.6×	124 0.8×	65 0.4×	35	433
Souzan Sanati United States	16	227 0.7×	160 0.7×	241 1.6×	196 1.3×	211 1.4×	30	611
Darryl Carter United States	11	118 0.4×	231 1.1×	226 1.5×	361 2.4×	137 0.9×	14	657
Eliana Gilioli Italy	10	342 1.1×	157 0.7×	81 0.5×	99 0.6×	360 2.4×	20	705
David Dusenbery United States	12	178 0.6×	227 1.0×	66 0.4×	123 0.8×	90 0.6×	23	458
Necati Alkış Türkiye	12	275 0.9×	113 0.5×	74 0.5×	56 0.4×	286 1.9×	41	554
S. Sahraoui Morocco	11	173 0.5×	98 0.5×	51 0.3×	83 0.5×	106 0.7×	106	449
T. Habeshaw United Kingdom	13	294 0.9×	139 0.6×	78 0.5×	42 0.3×	73 0.5×	28	516

Countries citing papers authored by Merrick I. Ross

Since Specialization

Citations

This map shows the geographic impact of Merrick I. Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Merrick I. Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merrick I. Ross more than expected).

Fields of papers citing papers by Merrick I. Ross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Merrick I. Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Merrick I. Ross. The network helps show where Merrick I. Ross may publish in the future.

Co-authorship network of co-authors of Merrick I. Ross

This figure shows the co-authorship network connecting the top 25 collaborators of Merrick I. Ross. A scholar is included among the top collaborators of Merrick I. Ross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Merrick I. Ross. Merrick I. Ross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Dummer, R., David Gyorki, John Hyngstrom, et al.. (2022). LBA39 Final 5-year results of the phase II, multicenter, randomized, open-label trial of talimogene laherparepvec (T-VEC) neoadjuvant treatment (Tx) plus surgery vs immediate surgery in patients (pts) with resectable stage IIIB-IVM1a melanoma (MEL). Annals of Oncology. 33. S1406–S1406. 2 indexed citations

Ross, Merrick I., Nicholas J. Bird, Iosif Mendichovszky, & Y. Rimmer. (2020). Neurologically asymptomatic cerebral oligometastatic prostate carcinoma metastasis identified on [Ga]Ga-THP-PSMA PET/CT. EJNMMI Research. 10(1). 108–108. 10 indexed citations

Leeuwen, Barbara L. van, Kari M. Rosenkranz, Liang Feng, et al.. (2010). The effect of under-treatment of breast cancer in women 80 years of age and older. Critical Reviews in Oncology/Hematology. 79(3). 315–320. 65 indexed citations

Ballo, Matthew T., Gunar K. Zagars, Erich M. Sturgis, et al.. (2004). Melanoma metastatic to cervical lymph nodes: Can radiotherapy replace formal dissection after local excision of nodal disease. International Journal of Radiation Oncology*Biology*Physics. 60. S256–S257. 2 indexed citations

Andtbacka, Robert H.I., Gildy V. Babiera, Eva S. Singletary, et al.. (2004). The incidence, prophylaxis and treatment of venous thromboembolism in patients undergoing breast cancer surgery. Journal of Clinical Oncology. 22(14_suppl). 616–616. 2 indexed citations

Porter, Geoffrey A., Merrick I. Ross, Russell S. Berman, et al.. (2000). How many lymph nodes are enough during sentinel lymphadenectomy for primary melanoma?. Surgery. 128(2). 306–311. 42 indexed citations

Janjan, Nora A., Haim Gutman, Robert S. Benjamin, et al.. (1999). Role of radiotherapy in sarcoma of the breast – a retrospective review of the M.D. Anderson experience. Radiotherapy and Oncology. 52(2). 173–178. 92 indexed citations

Bold, Richard J., Paul Mansfield, David Berger, et al.. (1998). Prospective, randomized, double-blind study of prophylactic antibiotics in axillary lymph node dissection. The American Journal of Surgery. 176(3). 239–243. 41 indexed citations

Bouvet, Michael, David W. Ollila, Kelly K. Hunt, et al.. (1997). Role of conservation therapy for invasive lobular carcinoma of the breast. Annals of Surgical Oncology. 4(8). 650–654. 35 indexed citations

10.

Berger, David H., Barry W. Feig, Donald A. Podoloff, et al.. (1997). Lymphoscintigraphy as a predictor of lymphatic drainage from cutaneous melanoma. Annals of Surgical Oncology. 4(3). 247–251. 41 indexed citations

11.

Schusterman, Mark A., Stephen S. Kroll, Michael Miller, et al.. (1994). The Free Transverse Rectus Abdominis Musculocutaneous Flap for Breast Reconstruction. Annals of Plastic Surgery. 32(3). 234–234. 138 indexed citations

12.

Janjan, Nora A., Alan W. Yasko, Gregory P. Reece, et al.. (1994). Comparison of charges related to radiotherapy for soft-tissue sarcomas treated by preoperative external-beam irradiation versus interstitial implantation. Annals of Surgical Oncology. 1(5). 415–422. 25 indexed citations

13.

Gutman, Haim, Raphael E. Pollock, Merrick I. Ross, et al.. (1994). Sarcoma of the breast: implications for extent of therapy. The M. D. Anderson experience.. PubMed. 116(3). 505–9. 82 indexed citations

14.

Morita, Tatsuo, et al.. (1992). Oligoclonal expansion of Vβ8+ cells in interleukin-2-activated T cells residing in subcutaneous metastatic melanoma. Clinical & Experimental Metastasis. 10(1). 69–76. 11 indexed citations

15.

Hayakawa, Kazuhiro, David Parkinson, Avi B. Markowitz, et al.. (1991). Study of Tumor-Infiltrating Lymphocytes for Adoptive Therapy of Renal Cell Carcinoma (RCC) and Metastatic Melanoma: Sequential Proliferation of Cytotoxic Natural Killer and Noncytotoxic T Cells in RCC. Journal of Immunotherapy. 10(5). 313–325. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact